JGMIX
Price
$25.00
Change
-$0.30 (-1.19%)
Updated
Jul 11 closing price
Net Assets
5.7B
VEXRX
Price
$106.61
Change
-$1.06 (-0.98%)
Updated
Jul 11 closing price
Net Assets
20.12B
Interact to see
Advertisement

JGMIX vs VEXRX

Header iconJGMIX vs VEXRX Comparison
Open Charts JGMIX vs VEXRXBanner chart's image
Janus Henderson Triton S
Price$25.00
Change-$0.30 (-1.19%)
VolumeN/A
Net Assets5.7B
Vanguard Explorer Adm
Price$106.61
Change-$1.06 (-0.98%)
VolumeN/A
Net Assets20.12B
JGMIX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JGMIX vs. VEXRX commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGMIX is a Buy and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.1B vs. JGMIX (5.7B). VEXRX pays higher dividends than JGMIX: VEXRX (0.52) vs JGMIX (0.00). JGMIX was incepted earlier than VEXRX: JGMIX (16 years) vs VEXRX (24 years). JGMIX (1.16) is less costly to investors than VEXRX (0.33). VEXRX is a more actively managed with annual turnover of: 35.00 vs. JGMIX (19.00). JGMIX has a lower initial minimum investment than VEXRX: JGMIX (2500) vs VEXRX (50000). JGMIX annual gain was more profitable for investors over the last year : -1.15 vs. VEXRX (-1.64). VEXRX return over 5 years is better than : 11.81 vs. JGMIX (-11.82).
JGMIXVEXRXJGMIX / VEXRX
Total Expense Ratio1.160.33352%
Annual Report Gross Expense Ratio1.160.33352%
Fund Existence16 years24 years-
Gain YTD2.082-0.225-927%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets5.7B20.1B28%
Annual Yield % from dividends0.000.52-
Returns for 1 year-1.15-1.6470%
Returns for 3 years3.8220.1819%
Returns for 5 years-11.8211.81-100%
Returns for 10 years-0.9115.36-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIS16.260.53
+3.37%
ProShares UltraShort Nasdaq Biotech
FAPR42.37N/A
N/A
FT Vest US Equity Buffer ETF Apr
DFAC36.38-0.23
-0.63%
Dimensional US Core Equity 2 ETF
GINN67.45-0.68
-1.00%
Goldman Sachs Innovate Equity ETF
FLSW37.87-0.55
-1.42%
Franklin FTSE Switzerland ETF